New drug ORKA-002 tested in humans for the first time
NCT ID NCT06944379
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 41 times
Summary
This Phase 1 trial is the first time ORKA-002 is being tested in humans. It involves 24 healthy adults to check the drug's safety, tolerability, and how the body processes it. Participants receive a single injection of either ORKA-002 or a placebo. The study is not designed to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oruka Therapeutics Investigative Site
Christchurch, New Zealand, New Zealand
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ORKA-002
What could go wrong
This is a very early Phase 1 trial with only 24 healthy people. It tests safety, not effectiveness, so it may not lead to any treatment.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.